Evidence map›Paper›PMID 11172010›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response.

S Peretz, R Jensen, R Baserga, P M Glazer

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01052623 (Status of the Growth Hormone/ Insulin-like Growth Factor-1), which is not on this map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01052623 phase4unknown statusnot on this mapstarted 2010, after this paper: background citation

Status of the Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis in Relation to Growth Failure, Body Weight and Neuroprotection in Children With Ataxia Telangiectasia

TypeinterventionalSponsorJohann Wolfgang Goethe University HospitalRan2010 to 2012Enrolled24ConditionsAtaxia Telangiectasia, Growth FailureArmsSomatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 146 citations in OpenAlex.

  1. ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia.European respiratory review : an official journal of the European Respiratory Society · 2015
    Guideline
  2. International journal of molecular medicine · 2021
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. The impact of the IGF-1 system of cancer cells on radiation response - AnClinical and translational radiation oncology · 2017
    Article
  10. Ataxia-Telangiectasia Mutated Kinase: Role in Myocardial Remodeling.Journal of rare diseases research & treatment · 2017
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Effects of aging on apoptosis gene expression in oral mucosal tissues.Apoptosis : an international journal on programmed cell death · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

S PeretzDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040, USA.
R Jensen
R Baserga
P M Glazer
Sidney Kimmel Cancer Center · USYale University · US

Funding

VIRAL SMALL RNPS--ROLES IN CELL TRANSFORMATIONP01CA016038 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL C. · 1985 to 2020
$25.6M
Oncometabolites, DNA Repair, and CancerR01ES005775 · NIEHS · YALE UNIVERSITY · PI PETER M GLAZER · 1998 to 2026
$8.0M
XRAY INDUCED MUTAGENESIS IN TRANSGENIC MICER29ES005775 · NIEHS · YALE UNIVERSITY · PI GLAZER, PETER M · 1992 to 1997
–
NCI NIH HHS CA16038NCI NIH HHS P01 CA016038NIEHS NIH HHS ES05775NIEHS NIH HHS R01 ES005775
6 · The paper itself

Abstract

The ATM gene is mutated in the syndrome of ataxia telangiectasia (AT), associated with neurologic dysfunction, growth abnormalities, and extreme radiosensitivity. Insulin-like growth factor-I receptor (IGF-IR) is a cell surface receptor with tyrosine kinase activity that can mediate mitogenesis, cell transformation, and inhibition of apoptosis. We report here that AT cells express low levels of IGF-IR and show decreased IGF-IR promoter activity compared with wild-type cells. Complementation of AT cells with the ATM cDNA results in increased IGF-IR promoter activity and elevated IGF-IR levels, whereas expression in wild-type cells of a dominant negative fragment of ATM specifically reduces IGF-IR expression, results consistent with a role for ATM in regulating IGF-IR expression at the level of transcription. When expression of IGF-IR cDNA is forced in AT cells via a heterologous viral promoter, near normal radioresistance is conferred on the cells. Conversely, in ATM cells complemented with the ATM cDNA, specific inhibition of the IGF-IR pathway prevents correction of the radiosensitivity. Taken together, these results establish a fundamental link between ATM function and IGF-IR expression and suggest that reduced expression of IGF-IR contributes to the radiosensitivity of AT cells. In addition, because IGF-I plays a major role in human growth and metabolism and serves as a survival and differentiation factor for developing neuronal tissue, these results may provide a basis for understanding other aspects of the AT syndrome, including the growth abnormalities, insulin resistance, and neurodegeneration.

Indexed as

Gene Expression RegulationLeucine ZippersAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell Line, TransformedCell SurvivalDNA-Binding ProteinsDNA, ComplementaryHumansPromoter Regions, GeneticProtein Serine-Threonine KinasesReceptor, IGF Type 1Tumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsDNA, ComplementaryProtein Serine-Threonine KinasesReceptor, IGF Type 1Tumor Suppressor Proteins

Identifiers

PMID11172010
PMCPMC29316
OpenAlexW2032134447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.